Annual EBIT
-$24.61 M
-$8.67 M-54.34%
December 31, 2022
Summary
- As of February 10, 2025, ACER annual earnings before interest & taxes is -$24.61 million, with the most recent change of -$8.67 million (-54.34%) on December 31, 2022.
- During the last 3 years, ACER annual EBIT has risen by +$5.28 million (+17.67%).
Performance
ACER EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBIT
-$4.29 M
+$694.80 K+13.93%
June 30, 2023
Summary
- As of February 10, 2025, ACER quarterly earnings before interest & taxes is -$4.29 million, with the most recent change of +$694.80 thousand (+13.93%) on June 30, 2023.
- Over the past year, ACER quarterly EBIT has increased by +$2.77 million (+39.21%).
Performance
ACER Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBIT
-$19.79 M
+$2.77 M+12.28%
June 30, 2023
Summary
- As of February 10, 2025, ACER TTM earnings before interest & taxes is -$19.79 million, with the most recent change of +$2.77 million (+12.28%) on June 30, 2023.
- Over the past year, ACER TTM EBIT has increased by +$2.02 million (+9.28%).
Performance
ACER TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ACER EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -54.3% | +39.2% | +9.3% |
| 3 y3 years | +17.7% | +25.6% | +7.1% |
| 5 y5 years | -76.5% | +12.6% | +33.8% |
ACER EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +54.3% | at low | at high | +64.5% | +24.1% | +24.4% |
| 5 y | 5-year | +54.3% | +21.5% | +31.0% | +64.5% | +24.1% | +51.1% |
| alltime | all time | >+9999.0% | +21.5% | >+9999.0% | +160.0% | >+9999.0% | +68.8% |
Acer Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$4.29 M(-13.9%) | -$19.79 M(-12.3%) |
| Mar 2023 | - | -$4.99 M(-5.2%) | -$22.56 M(-8.4%) |
| Dec 2022 | -$24.61 M(+54.3%) | -$5.26 M(+0.5%) | -$24.61 M(+3.5%) |
| Sep 2022 | - | -$5.24 M(-25.8%) | -$23.77 M(+9.0%) |
| Jun 2022 | - | -$7.06 M(+0.2%) | -$21.81 M(+18.7%) |
| Mar 2022 | - | -$7.05 M(+59.4%) | -$18.38 M(+15.2%) |
| Dec 2021 | -$15.95 M(-30.1%) | -$4.42 M(+34.8%) | -$15.95 M(-9.9%) |
| Sep 2021 | - | -$3.28 M(-9.7%) | -$17.70 M(-12.9%) |
| Jun 2021 | - | -$3.63 M(-21.4%) | -$20.31 M(-9.5%) |
| Mar 2021 | - | -$4.62 M(-25.2%) | -$22.45 M(-1.5%) |
| Dec 2020 | -$22.80 M(-23.7%) | -$6.17 M(+4.8%) | -$22.80 M(+4.5%) |
| Sep 2020 | - | -$5.89 M(+2.1%) | -$21.82 M(+2.5%) |
| Jun 2020 | - | -$5.77 M(+16.1%) | -$21.30 M(-20.2%) |
| Mar 2020 | - | -$4.97 M(-4.3%) | -$26.69 M(-10.7%) |
| Dec 2019 | -$29.90 M(+37.7%) | -$5.19 M(-3.2%) | -$29.90 M(-10.5%) |
| Sep 2019 | - | -$5.36 M(-52.0%) | -$33.40 M(+3.9%) |
| Jun 2019 | - | -$11.17 M(+36.6%) | -$32.15 M(+24.1%) |
| Mar 2019 | - | -$8.18 M(-6.0%) | -$25.90 M(+19.3%) |
| Dec 2018 | -$21.71 M(+55.7%) | -$8.70 M(+111.8%) | -$21.71 M(+26.0%) |
| Sep 2018 | - | -$4.11 M(-16.5%) | -$17.23 M(+4.5%) |
| Jun 2018 | - | -$4.92 M(+23.2%) | -$16.48 M(+34.6%) |
| Mar 2018 | - | -$3.99 M(-5.2%) | -$12.24 M(+33.4%) |
| Dec 2017 | -$13.95 M(+100.6%) | -$4.21 M(+25.4%) | -$9.17 M(+62.7%) |
| Sep 2017 | - | -$3.36 M(+395.3%) | -$5.64 M(+31.6%) |
| Jun 2017 | - | -$677.90 K(-26.8%) | -$4.29 M(-25.0%) |
| Mar 2017 | - | -$925.90 K(+36.5%) | -$5.72 M(-17.8%) |
| Dec 2016 | -$6.95 M(-42.5%) | -$678.10 K(-66.2%) | -$6.95 M(-20.0%) |
| Sep 2016 | - | -$2.00 M(-4.9%) | -$8.69 M(-8.5%) |
| Jun 2016 | - | -$2.11 M(-2.5%) | -$9.49 M(-12.9%) |
| Mar 2016 | - | -$2.16 M(-10.4%) | -$10.89 M(-9.9%) |
| Dec 2015 | -$12.09 M(-19.7%) | -$2.41 M(-14.0%) | -$12.09 M(-7.2%) |
| Sep 2015 | - | -$2.81 M(-20.0%) | -$13.04 M(-7.6%) |
| Jun 2015 | - | -$3.51 M(+4.4%) | -$14.11 M(-4.5%) |
| Mar 2015 | - | -$3.36 M(+0.1%) | -$14.77 M(-2.0%) |
| Dec 2014 | -$15.07 M(+4.7%) | -$3.36 M(-13.4%) | -$15.07 M(-2.6%) |
| Sep 2014 | - | -$3.88 M(-6.9%) | -$15.47 M(-8.8%) |
| Jun 2014 | - | -$4.17 M(+13.8%) | -$16.96 M(+9.4%) |
| Mar 2014 | - | -$3.66 M(-2.6%) | -$15.51 M(+7.8%) |
| Dec 2013 | -$14.39 M(+67.7%) | -$3.76 M(-30.1%) | -$14.39 M(+15.4%) |
| Sep 2013 | - | -$5.38 M(+98.4%) | -$12.47 M(+34.1%) |
| Jun 2013 | - | -$2.71 M(+6.6%) | -$9.30 M(+6.2%) |
| Mar 2013 | - | -$2.54 M(+38.5%) | -$8.75 M(+2.0%) |
| Dec 2012 | -$8.58 M(+43.8%) | -$1.84 M(-16.8%) | -$8.58 M(-0.5%) |
| Sep 2012 | - | -$2.21 M(+2.0%) | -$8.62 M(+11.8%) |
| Jun 2012 | - | -$2.16 M(-8.8%) | -$7.71 M(+9.6%) |
| Mar 2012 | - | -$2.37 M(+26.5%) | -$7.03 M(+17.9%) |
| Dec 2011 | -$5.97 M | -$1.88 M(+44.7%) | -$5.97 M(+18.8%) |
| Sep 2011 | - | -$1.30 M(-12.7%) | -$5.02 M(+0.1%) |
| Jun 2011 | - | -$1.49 M(+13.7%) | -$5.02 M(+1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2011 | - | -$1.31 M(+40.0%) | -$4.96 M(-0.2%) |
| Dec 2010 | -$4.97 M(+14.4%) | -$933.60 K(-27.6%) | -$4.97 M(-2.3%) |
| Sep 2010 | - | -$1.29 M(-9.8%) | -$5.09 M(+1.6%) |
| Jun 2010 | - | -$1.43 M(+8.5%) | -$5.01 M(+12.0%) |
| Mar 2010 | - | -$1.32 M(+25.2%) | -$4.47 M(+2.9%) |
| Dec 2009 | -$4.34 M(-63.7%) | -$1.05 M(-13.0%) | -$4.34 M(-17.7%) |
| Sep 2009 | - | -$1.21 M(+35.8%) | -$5.28 M(-26.9%) |
| Jun 2009 | - | -$891.10 K(-25.2%) | -$7.22 M(-27.9%) |
| Mar 2009 | - | -$1.19 M(-40.1%) | -$10.02 M(-16.3%) |
| Dec 2008 | -$11.97 M(-28.5%) | -$1.99 M(-36.9%) | -$11.97 M(-13.6%) |
| Sep 2008 | - | -$3.15 M(-14.6%) | -$13.86 M(-6.3%) |
| Jun 2008 | - | -$3.69 M(+17.4%) | -$14.79 M(-6.0%) |
| Mar 2008 | - | -$3.14 M(-19.0%) | -$15.73 M(-8.3%) |
| Dec 2007 | -$16.74 M(+24.1%) | -$3.88 M(-5.0%) | -$17.15 M(+11.9%) |
| Sep 2007 | - | -$4.08 M(-11.9%) | -$15.32 M(+0.5%) |
| Jun 2007 | - | -$4.63 M(+1.6%) | -$15.25 M(-3.5%) |
| Mar 2007 | - | -$4.56 M(+122.7%) | -$15.80 M(+17.1%) |
| Dec 2006 | -$13.49 M(+16.9%) | -$2.05 M(-48.9%) | -$13.49 M(-3.7%) |
| Sep 2006 | - | -$4.01 M(-22.7%) | -$14.01 M(+4.7%) |
| Jun 2006 | - | -$5.19 M(+130.8%) | -$13.39 M(+16.2%) |
| Mar 2006 | - | -$2.25 M(-12.5%) | -$11.52 M(-0.2%) |
| Dec 2005 | -$11.54 M(+206.9%) | -$2.57 M(-24.1%) | -$11.54 M(+4.5%) |
| Sep 2005 | - | -$3.39 M(+2.1%) | -$11.04 M(+33.5%) |
| Jun 2005 | - | -$3.32 M(+46.1%) | -$8.27 M(+51.2%) |
| Mar 2005 | - | -$2.27 M(+9.4%) | -$5.47 M(+69.6%) |
| Dec 2004 | -$3.76 M(+3089.2%) | -$2.07 M(+238.9%) | -$3.23 M(+173.9%) |
| Sep 2004 | - | -$612.10 K(+18.6%) | -$1.18 M(+80.3%) |
| Jun 2004 | - | -$516.20 K(+2050.8%) | -$653.50 K(+298.5%) |
| Mar 2004 | - | -$24.00 K(-6.6%) | -$164.00 K(-4.4%) |
| Dec 2003 | - | -$25.70 K(-70.7%) | -$171.50 K(-4.4%) |
| Sep 2003 | -$117.90 K(-18.2%) | -$87.60 K(+228.1%) | -$179.30 K(+57.4%) |
| Jun 2003 | - | -$26.70 K(-15.2%) | -$113.90 K(-7.5%) |
| Mar 2003 | - | -$31.50 K(-6.0%) | -$123.10 K(-4.6%) |
| Dec 2002 | - | -$33.50 K(+50.9%) | -$129.00 K(-10.5%) |
| Sep 2002 | -$144.20 K(-73.5%) | -$22.20 K(-38.2%) | -$144.20 K(-48.0%) |
| Jun 2002 | - | -$35.90 K(-4.0%) | -$277.50 K(-20.1%) |
| Mar 2002 | - | -$37.40 K(-23.2%) | -$347.20 K(-21.0%) |
| Dec 2001 | - | -$48.70 K(-68.7%) | -$439.40 K(-19.3%) |
| Sep 2001 | -$544.80 K(-35.7%) | -$155.50 K(+47.3%) | -$544.80 K(-27.9%) |
| Jun 2001 | - | -$105.60 K(-18.5%) | -$755.60 K(-11.0%) |
| Mar 2001 | - | -$129.60 K(-15.9%) | -$848.70 K(-5.3%) |
| Dec 2000 | - | -$154.10 K(-57.9%) | -$896.20 K(+7.2%) |
| Sep 2000 | -$846.90 K(+130.5%) | -$366.30 K(+84.3%) | -$836.30 K(+37.6%) |
| Jun 2000 | - | -$198.70 K(+12.2%) | -$607.80 K(+11.1%) |
| Mar 2000 | - | -$177.10 K(+88.0%) | -$547.10 K(+26.2%) |
| Dec 1999 | - | -$94.20 K(-31.6%) | -$433.50 K(+18.8%) |
| Sep 1999 | -$367.40 K | -$137.80 K(-0.1%) | -$364.80 K(+60.7%) |
| Jun 1999 | - | -$138.00 K(+117.3%) | -$227.00 K(+155.1%) |
| Mar 1999 | - | -$63.50 K(+149.0%) | -$89.00 K(+249.0%) |
| Dec 1998 | - | -$25.50 K | -$25.50 K |
FAQ
- What is Acer Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Acer Therapeutics?
- What is Acer Therapeutics annual EBIT year-on-year change?
- What is Acer Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Acer Therapeutics?
- What is Acer Therapeutics quarterly EBIT year-on-year change?
- What is Acer Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Acer Therapeutics?
- What is Acer Therapeutics TTM EBIT year-on-year change?
What is Acer Therapeutics annual earnings before interest & taxes?
The current annual EBIT of ACER is -$24.61 M
What is the all time high annual EBIT for Acer Therapeutics?
Acer Therapeutics all-time high annual earnings before interest & taxes is -$117.90 K
What is Acer Therapeutics annual EBIT year-on-year change?
Over the past year, ACER annual earnings before interest & taxes has changed by -$8.67 M (-54.34%)
What is Acer Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of ACER is -$4.29 M
What is the all time high quarterly EBIT for Acer Therapeutics?
Acer Therapeutics all-time high quarterly earnings before interest & taxes is -$22.20 K
What is Acer Therapeutics quarterly EBIT year-on-year change?
Over the past year, ACER quarterly earnings before interest & taxes has changed by +$2.77 M (+39.21%)
What is Acer Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of ACER is -$19.79 M
What is the all time high TTM EBIT for Acer Therapeutics?
Acer Therapeutics all-time high TTM earnings before interest & taxes is -$25.50 K
What is Acer Therapeutics TTM EBIT year-on-year change?
Over the past year, ACER TTM earnings before interest & taxes has changed by +$2.02 M (+9.28%)